Aura Biosciences (AURA) Interest Expenses (2022)

Aura Biosciences (AURA) has 7 years of Interest Expenses data on file, last reported at $23.5 million in Q1 2026.

• Quarterly Interest Expenses rose 805.47% year-over-year to $23.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 million (up 805.47% YoY) and the FY2025 annual result came in at $3.3 million, down 59.02% from the prior year.
• Interest Expenses rose to $23.5 million in Q1 2026, from $841000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $61.5 million in Q1 2022 to a low of $768000.0 in Q4 2022.
• A 5-year average of $16.9 million and a median of $11.5 million in 2023 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2022 — Interest Expenses jumped 69777.27% — and 2023, when it slumped 79.39%.
• Tracing AURA's Interest Expenses over 5 years: stood at $768000.0 in 2022, then grew by 3.26% to $793000.0 in 2023, then gained by 3.03% to $817000.0 in 2024, then advanced by 2.94% to $841000.0 in 2025, then jumped by 2695.01% to $23.5 million in 2026.
• The last three Interest Expenses figures came in at $23.5 million (Q1 2026), $841000.0 (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.